APG-157 / Aveta Biomics  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
APG-157 / Aveta Biomics
NCT05312710: Safety and Efficacy of APG-157 in Head and Neck Cancer

Recruiting
2
24
US
APG-157
Aveta Biomics, Inc.
Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity, Squamous Cell Carcinoma of the Oropharynx
07/24
07/24
NCT05865028: A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Recruiting
2
32
US
APG-157
Elizabeth J Franzmann, Aveta Biomics, Inc.
Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ
05/27
05/28
NCT06011109: Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Recruiting
1/2
30
US
APG-157
Aveta Biomics, Inc.
Glioma, Glioblastoma Multiforme
12/24
01/25

Download Options